| Mifeprex (mifepristone) / Danco Laboratories |
ChiCTR-TRC-11001438: Combination of mifepristone and misoprostol for termination of 8-16 weeks' pregancy: a multicenter, randomized controlled study |
|
|
| Completed | 4 | 1200 | | Day 1: mifepristone 200mg; Day 2: misoprostol vaginally 600mcg, q3h, up to 4 times ;Day 1: mifeprisone 200mg; Day 2: misoprostol vaginal 600mcg, then misoprostol orally after 3 h , up to 4 times ;Day 1: mifepristone 200mg; Day 2: misoprostol orally 600mcg, q3h, up to 4 times ;Day 1: mifepristone 100mg; Day 2: mifepristone 100mg; Day3: misoprostol 600mcg vaginal, q12h, up tp 3 times | Shanghai Institute of Planned Parenthood Research; Hualian Pharmaceutical Co., LTD, Shanghai Science and Technology Committee | medical abortion for 8-16 weeks' pregnancy | | | | |
2014-002974-35: Is home abortion mora acceptable for teenagers than abortion at the clinic? A randomized trial. |
|
|
| Ongoing | 4 | 160 | Europe | Tablet, Mifegyne, Cytotec, Naproxen, Alvedon | Umeå University, Umeå University | Young women with unwanted pregnancies seeking abortion care, Young women with unwanted pregnancies seeking abortion care, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
NCT01799928: Cervical Ripening Before Dilation and Evacuation |
|
|
| Recruiting | 4 | 50 | US | Placebo-Vitamin C pill, Osmotic Dilator, 400 mcg buccal misoprostol, 200 mg mifepristone | Oregon Health and Science University, Planned Parenthood Federation of America | Cervical Preparation Preoperatively to Dilation and Evacuation | 03/15 | | | |
2010-023849-30: The effects of MR and GR blockade on the reconsolidation and extinction of fear memories |
|
|
| Ongoing | 4 | 120 | Europe | Spironolactone, Mifepristone, RVG 18639, RVG 24206, Spironolactone, Mifepristone, Spironolactone, Mifepristone | University of Amsterdam | Fear conditioning acquisition, reconsolidation and extinction in healthy male subjects. | | | | |
2009-010277-21: A Randomised Controlled Trial on Efficacy of mifepristone followed by 6-8 hours versus 24 hours vaginal misoprostol in Early Pregnancy Abortions (< 63 days gestations) |
|
|
| Ongoing | 4 | 1200 | Europe | Mifepristone, Misoprostol, Mifegyne, Cytotec, Mifegyne, Cytotec | Calthorpe Clinic | Medical termination of pregnancies before nine weeks of pregnancy | | | | |
| Ongoing | 4 | 52 | Europe | Mifepristone, Mifegyne, Mifegyne | Kings College London, South London and Maudsley NHS Foundation Trust, Medical Research Council | Alcoholism | | | | |
2004-002920-17: A randomised preference trial of medical versus surgical termination of pregnancy less that 14 weeks\' gestation |
|
|
| Ongoing | 4 | 2232 | Europe | misoprostol, mifepristone, Cytotec, Mifegyne, Cytotec, Mifegyne | Department of Health | termination of pregnancy | | | | |
2013-001554-10: The comparison of two drug treatments for miscarriage Het vergelijken van twee medicamenteuze behandelingen bij een miskraam |
|
|
| Ongoing | 4 | 60 | Europe | Tablet, Mifegyne | Radboudumc, Radboudumc, Exelgyn, Canisius-Wilhelmina Ziekenhuis | Women aged above 18 years with early pregnancy failure, 6-14 weeks postmenstrual., Women with a miscarriage., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
ChiCTR-IPR-16007815: Evaluation of Therapeutic Effect and Safety of RU-486 in the Treatment of Adenomyosis with pain |
|
|
| Recruiting | 4 | 150 | | 2.5mg RU-486 po qd *12 months ;5mg RU-486 po qd*12 months ;25mg RU-486 po qw*11 months | Women's Hospital, School of Medicine, Zhejiang University; Women's Hospital, School of Medicine, Zhejiang University, self-financing | endometriosis and adenomyosis | | | | |
ChiCTR1800015514: Different low doses of mifepristone in the treatment of adenomyosis with dysmenorrhea: a non-randomized controlled study |
|
|
| Recruiting | 4 | 63 | | 2.5mg qd ;5mg qd ;25mg qw | Women's Hospital, School of Medicine, Zhejiang University; Women's Hospital, School of Medicine, Zhejiang University, self-financing | endometriosis and adenomyosis | | | | |
ChiCTR1900021247: A randomized, positive drug controlled, multi-center trial for Gongliuning in the treatment of uterine fibroids |
|
|
| Not yet recruiting | 4 | 520 | | Gongliuning tablets plus Mlfepristone ;Mifepristone ;Gonglouning tablets | Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Gansu Taikang Pharmaceutical Co., Ltd. | Uterine leiomyoma | | | | |
NCT04458558: Improving Access to Abortion in the Republic of Georgia |
|
|
| Recruiting | 4 | 120 | RoW | Mifepristone | Center for Information and Counseling on Reproductive Health - Tanadgoma, Gynuity Health Projects, Healthy Life, Grand Challenges Canada | Abortion Early, Pregnancy Related | 04/21 | 04/21 | | |
ChiCTR2000031656: Comparison of the therapeutic effect of Dinogest and mifepristone on adenomyosis |
|
|
| Not yet recruiting | 4 | 200 | | dinogest ;mifepristone ;GnRHa, dinogest ;GnRHa, mifepristone | Women's Hospital, School of Medicine, Zhejiang University; Women's Hospital, School of Medicine, Zhejiang University, none | Adenomyosis | | | | |
ChiCTR2000031689: Comparison of GnRHa and mifepristone in the treatment of symptomatic endometriosis |
|
|
| Recruiting | 4 | 60 | | GnRHa ;Mifepristone | Department of Gynecology and Obstetrics Hospital Affiliated to Zhejiang University Medical College; Level of the institution：, None | Endometriosis | | | | |
ChiCTR2000031698: Comparison of GnRHa and mifepristone in the treatment of adenomyosis: a randomized controlled trial. |
|
|
| Recruiting | 4 | 60 | | GnRHa ;Mifepristone | Women's Hospital, School of Medicine, Zhejiang University; Level of the institution：, none | aednomyosis | | | | |
ChiCTR2000041480: Randomized controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage |
|
|
| Recruiting | 4 | 294 | | mifepristone 200mg orally; letrozole 10mg once a day for 3 consecutive days | The University of Hong Kong - Shenzhen Hospital; The University of Hong Kong - Shenzhen Hospital, Department own funds | missed miscarriage | | | | |
| Completed | 4 | 538 | US | Mifepristone | Daniel Grossman, MD | Abortion Early, Pregnancy Related | 06/23 | 12/23 | | |
NCT05119439: Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks |
|
|
| Terminated | 4 | 23 | US | Mifepristone + 2 doses of misoprostol 800 mcg | Gynuity Health Projects, Society of Family Planning | Medical Abortion | 06/23 | 06/23 | | |
NCT05124314: Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss |
|
|
| Recruiting | 4 | 220 | RoW | Mifepristone, Oral, 200 Mg, Mifegyne, Misoprostol Pill, Mispregnol | Clinical Hospital Merkur, University of Zagreb School of Medicine | Abortion, Missed | 10/23 | 10/23 | | |
MIST, NCT05322252: Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial |
|
|
| Recruiting | 4 | 30 | US | Mifepristone, Misoprostol | Washington University School of Medicine | Abortion, Second Trimester, PPROM, Rupture, Spontaneous, Fetal Demise, Fetal Death, Fetal Demise From Miscarriage, Fetal Death Before 22 Weeks With Retention of Dead Fetus, Pregnancy Loss, Pregnancy Complications | 12/24 | 12/25 | | |
NCT05341817: The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy |
|
|
| Recruiting | 4 | 144 | RoW | Letrozole, Mifepristone | KK Women's and Children's Hospital | Abortion in First Trimester | 08/24 | 11/24 | | |
ACTRN12624000103561: Mifepristone versus placebo to increase the rate of spontaneous labour in people with a prior caesarean: A double blind randomised controlled trial
(Mi-labourTrial)
|
|
|
| Not yet recruiting | 3 | 168 | | | University of Auckland, Auckland Medical Research Foundation | vaginal birth after caesarean, labour | | | | |
| Recruiting | 3 | 20 | | | Neurological Foundation, Neurological Foundation | Diagnostic and Statistical Manual 4th edition (DSM-IV) Major Depressive Episode in patients with Parkinson's Disease. | | | | |
| Recruiting | 3 | 40 | | | FPA Health, FPA Health Foundation | The effect of administering a progestogen receptor modulator with or without oestrogen on the ovarian function and quality of cervical mucus in women using the progestogen-only sub-dermal contraceptive, Implanon. | | | | |
ChiCTR-IIR-15007521: The efficacy and safety of using mifepristone in the treatment of uterine fibroids: a randomized, multiple-center controlled trial |
|
|
| Completed | 3 | 300 | | Three months of daily therapy with oral mifepristone (at a dose of 10 mg) ;Three months of daily therapy with oral mifepristone (at a dose of 25 mg) ;once-monthly subcutaneous injections of enantone (at a dose of 3.75 mg) | Peking University First Hospital; Peking University First Hospital, CR Zizhu Pharmaceutical Co., Ltd | Uterine fibroids | | | | |
ChiCTR-IIR-15007522: The efficacy and safety of using mifepristone in the treatment of uterine fibroids: a randomized, double-blind, placebo-controlled clinical trial |
|
|
| Completed | 3 | 132 | | started from 1-3 days of the menstrual cycle, one tablet of 10 mg mifepristone taken orally every day for 84 days ;started from 1-3 days of the menstrual cycle, one placebo tablet taken orally every day for 3 months | Peking University First Hospital; Peking University First Hospital, CR Zizhu Pharmaceutical Co., Ltd | Uterine fibroids | | | | |
| Ongoing | 3 | 670 | Europe | Medabon (mifepriston och misoprostol), G03XB01, Tablet, Sublingual tablet, Medabon (Mifepristone, Misoprostol), misoprostol | Concept Foundation, Concept Foundation | Termination of unwanted pregnancies of 64-140 days from last menses (verified by ultrasound), Termination of unwanted pregnancy, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2009-017222-39: Ensayo clínico aleatorizado, doble ciego, doble enmascarado, multicéntrico para evaluar la eficacia y seguridad de 5 mg de mifepristona oral comparado con triptorelina IM administrados durante 4 meses en el tratamiento de fibroma uterino |
|
|
| Ongoing | 3 | 74 | Europe | mifepristona, -, DECAPEPTYL MENSUAL 3,75 mg, polvo y disolvente para suspensión inyectable, DECAPEPTYL MENSUAL 3,75 mg, polvo y disolvente para suspensión inyectable | Laboratorios Litaphar S.A. | fibroma uterino | | | | |
2016-003753-14: CERVICAL PREPARATION UNDER PARACERVICAL BLOCK FOR THE ABORTION OF FIRST TRIMESTER: RANDOMIZED TRIAL PREPARATION CERVICALE DES IVG SOUS BLOC PARACERVICAL AU 1er TRIMESTRE: ESSAI CLINIQUE RANDOMISE |
|
|
| Not yet recruiting | 3 | 1 | Europe | MIFEGYNE, GYMISO200MICROG, MIFEPRISTONE, GYMISO 200MICROG, Cachet, MIFEPRISTONE 200 MG, GYMISO 200MICROG | Assistance Publique Hôpitaux de Marseille, AP-HM | The women are 18 years old or more, wishing an abortion under local anesthesia, between 6 and 14 weeks the day of the abortion. Patiente de 18 ans ou plus, désirant une interruption volontaire de grossesse (IVG) sous anesthésie locale (AL), entre 6semaines d'aménorhée (SA) et 14SA le jour de l'IVG, The women are 18 years old or more, wishing an abortion under local anesthesia, between 6 and 14 weeks the day of the abortion. Patiente de 18 ans ou plus, désirant une interruption volontaire de grossesse (IVG) sous anesthésie locale, entre 6SA et 14SA le jour de l'IVG, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2018-002367-26: Parallel group, blinded, multi-centre study of mifepristone in patients with endometriosis |
|
|
| Ongoing | 3 | 490 | Europe | Mifepristone 2.5 mg tablets, Mifepristone 5 mg tablets, Mifepristone 2.5 mg tablets, Mifepristone 5 mg tablets, Tablet | Litaphar Laboratorios, Litaphar Laboratorios | endometriosis in reproductive-age, endometriosis in reproductive-age, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2020-004302-63: A multi-centre, open-label, single-arm study assessing the safety and efficacy of 5 mg of mifepristone for the treatment of endometriosis in reproductive-age women during two treatment cycles of 24 weeks each |
|
|
| Ongoing | 3 | 300 | Europe | Mifepristone 5 mg, Mifepristone 5 mg, Tablet | Litaphar Laboratorios S.L., Litaphar Laboratorios S.L. | endometriosis in reproductive-age, endometriosis in reproductive-age, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
NCT05016349: Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. |
|
|
| Not yet recruiting | 3 | 160 | NA | All trans-retinoic acid, Vesanoid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone, Cannabidiol, Epidiolex, 9 cis retinoic acid, Tamoxifen, Standard therapy | Mahmoud Ramadan mohamed Elkazzaz, Ministry of Health, Saudi Arabia | Breast Cancer Female | 10/21 | 12/21 | | |
| Completed | 3 | 30 | US | Mifepristone, Misoprostol | Stanford University | Induced Vaginal Delivery | 04/23 | 04/23 | | |
NCT05304273: Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages |
|
|
| Recruiting | 3 | 120 | RoW | Mifepristone, Misoprostol 800 microgram vaginally, Letrozole | Calcutta National Medical College and Hospital | Miscarriage | 04/24 | 05/24 | | |
NCT05839899: Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location |
|
|
| Recruiting | 3 | 50 | US | Mifepristone plus one dose Misoprostol, Mifepristone plus two doses Misoprostol | Planned Parenthood League of Massachusetts | Abortion | 07/24 | 09/24 | | |
WOMEN, NCT06394999: Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive |
|
|
| Not yet recruiting | 3 | 1186 | Europe | Mifepristone 50 mg | Leiden University Medical Center, Karolinska Institutet, Women on Waves, Children's Investment Fund Foundation | Female Contraception | 09/28 | 09/29 | | |
| Recruiting | 3 | 400 | Europe | Mifepristone, Placebo | Chelsea and Westminster NHS Foundation Trust | Labor, Induced | 10/25 | 10/26 | | |
2006-002596-40: Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination: a randomized, placebo-controlled, multicentre trial |
|
|
| Ongoing | 2/3 | 188 | Europe | Cytotec, Mifegyne, Cytotec, Mifegyne, Cytotec | World Health Organization | Termination of early pregnancy | | | | |
ACTRN12620000596909p: Progesterone after mifepristone, for women whose decision has changed after commencing a medical termination of pregnancy - a pilot clinical trial |
|
|
| Not yet recruiting | 2 | 52 | | | University of New England, University of New England | Pregnancy continuation after mifepristone | | | | |
ACTRN12605000206628: Control of menstrual bleeding disturbances in women using Implanon contraception |
|
|
| Recruiting | 2 | 500 | | | FPA Health, 328 Liverpool Rd Ashfield NSW 2131, National Institutes of Health | Breakthrough bleeding with Implanon progestogen-only contraception | | | | |
ACTRN12620000596909: Progesterone after mifepristone, for women whose decision has changed after commencing a medical termination of pregnancy - a pilot clinical trial |
|
|
| Recruiting | 2 | 52 | | | University of New England, University of New England, Australasian Pharmaceutical Science Association (APSA) | Pregnancy continuation after mifepristone | | | | |
NCT01946685: A Randomized Clinical Trial of Mifepristone in PTSD |
|
|
| Recruiting | 2 | 136 | US | 600 mg/day Mifepristone, Placebo | James J. Peters Veterans Affairs Medical Center, San Diego Veterans Healthcare System, Durham VA Medical Center | PTSD | 11/15 | 06/16 | | |
2005-004940-29: VOLUNTARY TERMINATION OF PREGNANCY WITH MIFEPRISTONE RU486 AND MISOPROSTOL |
|
|
| Ongoing | 2 | 400 | Europe | Misoprostol, Mifegyne, Mifegyne | AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA | VOLUNTARY TERMINATION OF PREGNANCY LAW N.194/1978 | | | | |
2007-007604-15: A Pilot Study of the Effect of Glucocorticoid Receptor Antagonism in Patients with Sub-Clinical Cushing\'s Syndrome |
|
|
| Ongoing | 2 | 6 | Europe | HRA052015 (mifepristone), HRA052015, mifedren, mifedren | Sheffield Teaching Hospitals NHS Foundation Trust | Sub Clinical Cushing\'s Syndrome | | | | |
2008-005829-11: Mifepristona en la prevención del síndrome de hiperestimulación ovárica en tratamientos de reproducción asistida |
|
|
| Ongoing | 2 | 90 | Europe | Mifegyne, Mifegyne | FUNDACION CV INVESTIGACION HOSPITAL DR PESET | Mifepristona en la prevención del síndrome de hiperestimulación ovárica en tratamientos de reproducción asistida | | | | |
NCT04676776: Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills" |
|
|
| Recruiting | 2 | 139 | RoW | Levonorgestrel, Mifepristone | Gynuity Health Projects, Cuidado Integral de la Mujer, Gineclinic, S.C. | Missed Menstrual Period | 12/21 | 12/21 | | |
NCT03972358: Assessing Medical Menstrual Regulation in the United States |
|
|
| Recruiting | 2 | 284 | US | Mifepristone, Misoprostol | Gynuity Health Projects | Menstrual Regulation | 12/21 | 12/21 | | |
2019-002032-84: Evaluating the effect of a drug that at full-term preganacy, softens the neck of the womb ready for delivery Hodnocení účinku přípravku, který v období dosažení termínu porodu změkčuje hrdlo dělohy připravené na porod |
|
|
| Not yet recruiting | 2 | 150 | RoW | Mifepristone 150, Mifepristone 75, Tablet | Disphar International B.V, Disphar International B.V. | Full-term pregnancy women at week 40 + 5 of gestation with intact membranes, the first delivery, singleton physiological pregnancy těhotné ženy po dosažení termínu porodu ve stadiu týden 40 + 5 s intaktními membránami, prvorodičky, jednočetné fyziologické těhotenství, pregnant women at week 40 + 5 days of pregnancy giving birth for the first time, singleton (one fetus) pregnancy without medical complications těhotné ženy ve stadiu těhotenství 40 týdnů + 5 dní, první porod, jednočetné těhotenství bez zdravotních komplikací, Body processes [G] - Reproductive physiologi cal processes [G08] | | | | |
RESET-m, NCT05217758: edication Glucocorticoid Receptor (GR) Blockade as Disease Modifying Treatment for Depression With Childhood Trauma |
|
|
| Recruiting | 2 | 158 | Europe | Mifepristone, Placebo | VU University Medical Center, Netherlands Brain Foundation, Corcept Therapeutics | Major Depressive Disorder, Childhood Trauma | 12/23 | 06/24 | | |
NCT03225547: Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer |
|
|
| Active, not recruiting | 2 | 74 | US | Pembrolizumab, Keytruda, Mifepristone, Mifeprex | University of Chicago | Triple Negative Breast Neoplasms, Breast Cancer | 09/25 | 09/25 | | |
TBCRC 058, NCT06099769: A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
|
|
| Recruiting | 2 | 201 | US | Enzalutamide, Mifepristone, TPC | Memorial Sloan Kettering Cancer Center, Astellas Pharma US, Inc., Breast Cancer Research Foundation, Corcept Therapeutics | Metastatic Breast Cancer | 10/27 | 10/27 | | |
ChiCTR2100043789: Pharmacokinetics and Bioequivalence study of Mifepristone tablet in Healthy Chinese Volunteers |
|
|
| Recruiting | 1 | 52 | | fasted state T-R ;fasted state R-T | People′s Hospital of Deyang City; Zhejiang Xianju Pharmaceutical Co., Ltd., Zhejiang Xianju Pharmaceutical Co.,Ltd. | Diseases of reproductive system | | | | |
NCT04254627: TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset |
|
|
| Recruiting | 1 | 20 | US | Etanercept, Enbrel, Mifepristone, Mifeprex, RU-486 | Nova Southeastern University, RTI International, Miami VA Healthcare System | Gulf War Illness | 07/24 | 09/24 | | |
| Not yet recruiting | 1 | 140 | RoW | mifepristone, Triptorelin Acetate | Women's Hospital School Of Medicine Zhejiang University, Ningbo Women & Children's Hospital, Jiaxing Maternity and Child Health Care Hospital, The Affiliated Hospital of Medical School, Ningbo University, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, The First Affiliated Hospital with Nanjing Medical University, Anhui Provincial Hospital | Adenomyosis, Mifepristone | 12/23 | 12/23 | | |
ChiCTR-IOR-15007664: A randomized clinical trial comparing the efficacy of drug and artificial abortion. |
|
|
| Not yet recruiting | N/A | 200 | | mifepristone and misoprostol ;Curettage | Reproductive Hospital Affiliated to Shandong University; Reproductive Hospital Affiliated to Shandong University, hospital funding | arrested pregnancy with 14 week's gestation | | | | |
ChiCTR-INR-17014174: Effect of GnRH- antagonist combined with mifepristone and letrozole on early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized controlled study |
|
|
| Recruiting | N/A | 152 | | combination of GnRH - A and letrozole with mifepristone will be used for High-risk early-onset OHSS patients after oocyte retrieval ;mifepristone will be used for High-risk early-onset OHSS patients after oocyte retrieval | International Affairs Office, Wuhan University Renmin Hospital (Hubei General Hospital); International Affairs Office, Wuhan University Renmin Hospital (Hubei General Hospital), self-financing | Ovarian hyperstimulation syndrome | | | | |
ChiCTR2100046503: Analysis on the etiology and outcome of missed abortion caused by uterine environment |
|
|
| Recruiting | N/A | 96 | | Mifepristone combined with estradiol valerate ;Estradiol valerate ;Mifepristone ;Basic medicine | The First Affiliated Hospital of Chongqing Medical University; The First Affiliated Hospital of Chongqing Medical University, NO | Early pregnancy loss | | | | |
NCT03440866: Comparison of the Effectiveness of Treatment With Mifepristone and Misoprostol at the Same Time Compared to the Administration of Drugs at a 48-hour Interval for Medical Abortion. |
|
|
| Active, not recruiting | N/A | 250 | RoW | Administration of drugs concomitantly., no interval | HaEmek Medical Center, Israel | Early Pregnancy | 12/21 | 12/23 | | |
NCT04271722: Clinical Evaluation of Cervical Ripening in the Outpatient Setting |
|
|
| Completed | N/A | 101 | Europe | Cervical ripening | Centro Hospitalar Lisboa Norte | Labor; Forced or Induced, Affecting Fetus or Newborn, Labor Onset and Length Abnormalities | 12/22 | 12/22 | | |
HYMMN, NCT04751500: The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC |
|
|
| Completed | N/A | 149 | Europe | Outpatient hysteroscopy, Expectant management, Medical management, misoprostol, mifepristone, Antibiotic, Augmentin, Co-amoxiclav, Metronidazole, Clindamycin, Surgical management, manual vacuum aspiration, suction evacuation of the uterus, dilatation and currettage | Birmingham Women's and Children's NHS Foundation Trust, Tommy's | Retained Products After Miscarriage | 11/22 | 11/22 | | |
| Completed | N/A | 306 | Europe | scale of pain | Assistance Publique Hopitaux De Marseille | Abortion-Related Disorders | 03/23 | 04/23 | | |
ChiCTR2200061298: Clinical study of low dose mifepristone combined with high intensity focused ultrasound in the treatment of uterine fibroids |
|
|
| Recruiting | N/A | 100 | | Oral mifepristone for 3 months ;No | Affiliated Hospital of North Sichuan Medical College; Affiliated Hospital of North Sichuan Medical College, individual | uterine fibroids | | | | |
MiMAC, NCT04905251: Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion |
|
|
| Recruiting | N/A | 3000 | Canada | Mifepristone-Misoprostol | Linepharma International LTD | Medical Abortion | 06/23 | 12/23 | | |
IMEGYN, NCT03194126: Evaluation of Efficacy of Two Therapeutic Strategies for Cervical Maturation Before Medical Termination |
|
|
| Completed | N/A | 120 | Europe | Mifepristone + Misoprostol OR oxytocine + laminaria, Mifepristone + Misoprostol OR oxytocine | Centre Hospitalier Universitaire de Nīmes | Medical; Abortion, Fetus | 09/23 | 09/23 | | |
ChiCTR2200065595: Exploratory Clinical Study on Mifepristone for the Treatment of Recurrent Glioblastoma |
|
|
| Not yet recruiting | N/A | 20 | | Administration of Mifepristone | Huashan Hospital, Fudan University; Huashan Hospital, Self Funding | Recurrent Glioblastoma | | | | |
TCRM, NCT05898321: To Prevent Type I-II Myoma After Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone |
|
|
| Not yet recruiting | N/A | 294 | RoW | Zoladex, Mifepristone Oral Tablet | Women's Hospital School Of Medicine Zhejiang University | Submucous Leiomyoma of Uterus | 12/24 | 12/25 | | |
| Recruiting | N/A | 576 | | | World Health Organization, World Health Organization
Department of Reproductive Health and Research | Medical Abortion, Pain management | | | | |